Private Capital's LLY Position Overview
Private Capital (via Private Capital Management, LLC) currently holds 425 shares of Eli Lilly and Company (LLY) worth $510,008, representing 0.04% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Private Capital has maintained this position in LLY for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 96 shares.
Analysis based on 13F filings available since 2013 Q2
Private Capital's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Private Capital
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +2 | Add 0.47% | 425 | $1200.02 |
| Q1 2026 | +96 | Add 29.36% | 423 | $919.91 |
| Q4 2025 | +327 | New Buy | 327 | $1074.74 |
Private Capital's Eli Lilly and Company Investment FAQs
Private Capital first purchased Eli Lilly and Company (LLY) in Q4 2025, acquiring 327 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital has held Eli Lilly and Company (LLY) for 3 quarters since Q4 2025.
Private Capital's largest addition to Eli Lilly and Company (LLY) was in Q4 2025, adding 327 shares worth $351,441.
According to the latest 13F filing for Q2 2026, Private Capital's firm, Private Capital Management, LLC, owns 425 shares of Eli Lilly and Company (LLY), valued at approximately $510,008.
As of the Q2 2026 filing, Eli Lilly and Company (LLY) represents approximately 0.04% of Private Capital's publicly disclosed stock portfolio, making it one of their key holdings.
Private Capital's peak holding in Eli Lilly and Company (LLY) was 425 shares, as reported at the end of Q2 2026.